Exposure of Infants to Isoniazid via Breast Milk After Maternal Drug Intake of Recommended Doses Is Clinically Insignificant Irrespective of Metaboliser Status. A Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach to Estimate Drug Exposure of Infants via Breast-Feeding

Isoniazid is a first-line anti-tuberculosis drug recommended for treatment of drug-susceptible Mycobacterium tuberculosis infections. Breast-feeding is not contra-indicated while undergoing isoniazid therapy, even though isoniazid was found to migrate into breast milk, leading to infant drug exposur...

Descripción completa

Detalles Bibliográficos
Autores principales: Garessus, Estella Dora Germaine, Mielke, Hans, Gundert-Remy, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349757/
https://www.ncbi.nlm.nih.gov/pubmed/30723406
http://dx.doi.org/10.3389/fphar.2019.00005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349757/
https://www.ncbi.nlm.nih.gov/pubmed/30723406
http://dx.doi.org/10.3389/fphar.2019.00005

Ejemplares similares